HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A cyclooxygase-2 inhibitor NS-398-enhanced apoptosis of esophageal carcinoma cell EC9706 by adjusting expression of survivin and caspase-3.

Abstract
The aim of this study is to examine the effect and mechanism of a selective cyclooxygenase-2 (COX-2) inhibitor NS-398 on inducing apoptosis of esophageal cancer cells. After the treatment with NS-398 on esophageal carcinoma EC9706 cell, MTT assay was used to observe the inhibition of EC9706 cell growth and apoptosis was determined by electronic microscopy and flow cytometry. The expression of survivin and caspase-3 was examined using immunocytochemical technique. The dose of 0.01–0.1 mM NS398 showed the inhibitory effect on growth of EC9706 cell lines and induce apoptosis in a dose- and time-effective manner; moreover, NS-398 also downregulated the level of expression of survivin and elevated the expression of capase-3. NS-398 can induce apoptosis of the esophageal carcinoma EC9706 cells by means of adjusting expression of survivin and caspase-3.
AuthorsShengbao Li, Dean Tian, Pei Fei, Yuanjun Gao, Zihua Chen, Qiang Wang, Qiang Tong
JournalCancer investigation (Cancer Invest) Vol. 29 Issue 2 Pg. 102-6 (Feb 2011) ISSN: 1532-4192 [Electronic] England
PMID21329005 (Publication Type: Journal Article)
Chemical References
  • BIRC5 protein, human
  • Cyclooxygenase 2 Inhibitors
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins
  • Nitrobenzenes
  • Sulfonamides
  • Survivin
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Caspase 3
Topics
  • Apoptosis (drug effects)
  • Caspase 3 (analysis)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cyclooxygenase 2 Inhibitors (pharmacology)
  • Esophageal Neoplasms (chemistry, drug therapy, pathology)
  • Humans
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins (analysis)
  • Nitrobenzenes (pharmacology)
  • Sulfonamides (pharmacology)
  • Survivin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: